CUSIP G0593M107 · who reports it, how much, and how much it matters to them
41 of the 720 hedge fund managers we track reported shares of Astrazeneca plc (NYSE: AZN) on Form 13F for 30 June 2026. Between them they reported USD 2.1bn. The largest position belongs to Holocene Advisors, at USD 461m. The manager with the most riding on it is Artia Global Partners, where it is 3.4% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Holocene Advisors2 funds on PPLI.com | USD 461m | 1.0% |
| 2 | Polar Capital LLP26 funds on PPLI.com | USD 237m | 0.6% |
| 3 | D. E. Shaw & Co.15 funds on PPLI.com | USD 208m | 0.1% |
| 4 | Citadel Advisors32 funds on PPLI.com | USD 184m | 0.0% |
| 5 | Orbimed Advisors1 fund on PPLI.com | USD 171m | 3.2% |
| 6 | Marshall Wace LLP84 funds on PPLI.com | USD 160m | 0.1% |
| 7 | POINT72 Asset Management17 funds on PPLI.com | USD 135m | 0.1% |
| 8 | Millennium Management6 funds on PPLI.com | USD 110m | 0.0% |
| 9 | Farallon Capital Management56 funds on PPLI.com | USD 109m | 0.5% |
| 10 | Artisan Partners1 fund on PPLI.com | USD 70m | 0.1% |
| 11 | Two Sigma Investments35 funds on PPLI.com | USD 62m | 0.0% |
| 12 | Glenview Capital Management9 funds on PPLI.com | USD 35m | 0.6% |
| 13 | Voleon Capital Management13 funds on PPLI.com | USD 24m | 0.4% |
| 14 | Barings1 fund on PPLI.com | USD 24m | 0.4% |
| 15 | Ninety One North America3 funds on PPLI.com | USD 23m | 1.1% |
| 16 | Artia Global Partners1 fund on PPLI.com | USD 19m | 3.4% |
| 17 | Aquatic Capital Management3 funds on PPLI.com | USD 13m | 0.4% |
| 18 | Sphera Funds Management1 fund on PPLI.com | USD 12m | 1.5% |
| 19 | CIBC Asset Management69 funds on PPLI.com | USD 11m | 0.0% |
| 20 | Platinum Investment Management11 funds on PPLI.com | USD 9m | 2.2% |
| 21 | Tudor Investment Corporation10 funds on PPLI.com | USD 7.5m | 0.0% |
| 22 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 5.4m | 0.3% |
| 23 | Brevan Howard Capital Management39 funds on PPLI.com | USD 3.8m | 0.0% |
| 24 | LMR Partners2 funds on PPLI.com | USD 2.9m | 0.0% |
| 25 | Verition Fund Management3 funds on PPLI.com | USD 2.4m | 0.0% |
| 26 | Exome Asset Management2 funds on PPLI.com | USD 2.3m | 1.4% |
| 27 | Jain Global1 fund on PPLI.com | USD 1.6m | 0.0% |
| 28 | Lighthouse Investment Partners190 funds on PPLI.com | USD 1.4m | 0.0% |
| 29 | Graham Capital Management18 funds on PPLI.com | USD 1.1m | 0.0% |
| 30 | Cinctive Capital Management5 funds on PPLI.com | USD 1.1m | 0.0% |
| 31 | LMCG Investments2 funds on PPLI.com | USD 997,000 | 0.1% |
| 32 | Persistent Asset Partners10 funds on PPLI.com | USD 769,000 | 0.2% |
| 33 | Boothbay Fund Management2 funds on PPLI.com | USD 741,000 | 0.0% |
| 34 | Engineers Gate Manager1 fund on PPLI.com | USD 613,000 | 0.0% |
| 35 | Permanens Capital6 funds on PPLI.com | USD 342,000 | 0.0% |
| 36 | Prescott Group Capital Management3 funds on PPLI.com | USD 235,000 | 0.0% |
| 37 | Seelaus Asset Management8 funds on PPLI.com | USD 212,000 | 0.1% |
| 38 | The Quarry1 fund on PPLI.com | USD 30,855 | 0.0% |
| 39 | Summit Global Investments1 fund on PPLI.com | USD 1,241 | 0.1% |
| 40 | Walleye Capital8 funds on PPLI.com | USD 1,138 | 0.0% |
| 41 | The Bollard Group7 funds on PPLI.com | USD 52 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Artia Global Partners | USD 19m | 3.4% |
| 2 | Orbimed Advisors | USD 171m | 3.2% |
| 3 | Platinum Investment Management | USD 9m | 2.2% |
| 4 | Sphera Funds Management | USD 12m | 1.5% |
| 5 | Exome Asset Management | USD 2.3m | 1.4% |
| 6 | Ninety One North America | USD 23m | 1.1% |
| 7 | Holocene Advisors | USD 461m | 1.0% |
| 8 | Glenview Capital Management | USD 35m | 0.6% |
| 9 | Polar Capital LLP | USD 237m | 0.6% |
| 10 | Farallon Capital Management | USD 109m | 0.5% |
Astrazeneca plc trades under the symbol AZN on the New York Stock Exchange. Its CUSIP, the code used on Form 13F, is G0593M107.
41 of the 720 hedge fund managers PPLI.com tracks reported Astrazeneca plc shares on Form 13F for 30 June 2026. The largest reported positions were held by Holocene Advisors (USD 461m), Polar Capital LLP (USD 237m), D. E. Shaw & Co. (USD 208m), Citadel Advisors (USD 184m) and Orbimed Advisors (USD 171m).
41 managers in our coverage reported it, and between them they run 713 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Artia Global Partners, where the position was 3.4% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Astrazeneca plc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.